petosemtamab
merus
['petosemtamab', 'merus ']
hope to see you monday at #aacr23. we re excited to present new data on petosemtamab monotherapy in previously treated #hnscc.
#closeinoncancer 
Clinical-stage oncology company developing Biclonics® bispecific antibody therapeutics. Please see our Community Guidelines: https://t.co/qN9crK04bE